NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
Adjusted price
+4.71% total return, past year
Key statistics
- Market cap
- $14.6B
- P/E (TTM)
- 21.0
- 52-week range
- $123.10$185.50
- Beta (5Y monthly)
- 0.40
- Median dollar volume
- $166M
- Shares outstanding
- 101.6M
- Revenue, last 12 months
- $3.4B
- Sector
- Health Care
- First close
- May 23, 1996
Returns
Total
- 1M
- −9.3%
- YTD
- +1.0%
- 1Y
- +4.7%
Per year
- 3Y
- +8.6%
- 5Y
- +7.1%
- 10Y
- +11.0%
- 20Y
- +13.8%
- Since 1996
- +8.4%
Financials
Annual returns
1996 from May 23 · 2026 through Oct 2